Associations between menarche-related genetic variants and pubertal growth in male and female adolescents by Tu, Wanzhu et al.
Associations Between Menarche-related Genetic Variants and 
Pubertal Growth in Male and Female Adolescents
Wanzhu Tu, Ph.D.a, Erin K. Wagner, Ph.D.b, George J. Eckert, M.A.S.a, Zhangsheng Yu, 
Ph.D.a, Tamara Hannon, M.D.c, J. Howard Pratt, M.D.d,e, and Chunyan He, Sc.D.b,f,*
aDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana
bDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, 
Indianapolis, Indiana
cDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana
dDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
eThe Veterans Affairs Medical Center, Indianapolis, Indiana
fMelvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana
Abstract
Purpose—Previous studies have identified novel genetic variants associated with age at 
menarche in females of European descent. The pubertal growth effects of these variants have not 
been carefully evaluated in non-European descent groups. We aimed to examine the effects of 31 
newly identified menarche-related single nucleotide polymorphisms (SNPs) on growth outcomes 
in African American (AA) and European American (EA) children in a prospective cohort.
Methods—We analyzed longitudinal data collected from 263 AA and 338 EA enrolled between 
ages 5 and 17 years; the subjects were followed semiannually for an average of 6 years. The 
associations between the SNPs and growth-related outcomes, including weight, height, and body 
mass index (BMI), were examined using mixed-effect models.
Results—Longitudinal analyses revealed that 4 (near or in genes VGLL3, PEX2, CA10, and 
SKOR2) out of the 14 menarche-only related SNPs were associated with changes in weight and 
BMI in EA and AA (P≤0.0032), but none of them were associated with changes in height. Of the 8 
menarche-timing and BMI-related SNPs, none was associated with changes in height, but 3 (in or 
near genes NEGR1, ETV5, and FTO) were associated with more rapid increases in weight and/or 
BMI in EA (P≤0.0059). Among the 9 menarche-timing and height-related SNPs, 4 (in or near 
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genes ZBTB38, LOC728666, TBX2 and CABLES) were associated with changes in weight or 
height in EA and AA (P≤0.0042).
Conclusion—Genetic variants related to age at menarche were found to be associated with 
various growth parameters in healthy adolescents. The identified associations were often race and 
sex-specific.
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Introduction
Puberty, the period of transition from childhood to adulthood, is characterized by 
accelerated growth and sexual maturation. The regulation of puberty is complex and partly 
influenced by individual’s genetic background[1]. Genetic variation affecting events 
associated with puberty may relate to future disease risks. For example, previous studies 
have linked younger menarcheal age to increased later-in-life risks of obesity, type 2 
diabetes, breast and endometrial cancer, and cardiovascular diseases[2–5]. During puberty, 
timing of menarche is in general well synchronized with somatic change. A higher 
childhood body mass index (BMI) has been shown to associate with early onset of 
menarche[6, 7], suggesting a direct influence of adiposity on the timing of sexual maturity. 
The influence, however, may not be unidirectional as data suggest that female puberty is 
often accompanied by rapid gains in body weight and body fat[8, 9]. Although the causal 
direction remains uncertain, data are consistent on the correlation between menarcheal 
timing and body fat accumulation, as reflected by increased BMI; this correlation points to 
the possible existence of common regulating mechanisms shared by these two processes. It 
is thought that a significant portion of the shared genes account for the correlation between 
increased childhood adiposity and early sexual maturation as indicated by the onset of 
menarche[10].
Menarche, the occurrence of the first menstrual cycle, is considered a landmark event of 
female puberty. Genetic factors are thought to account for approximately 50% of the 
observed variation in timing of menarche[11, 12]. Previous genome-wide association studies 
(GWAS) identified variants in LIN28B that associated with age at menarche in women of 
European ancestry[13–16]. The growth effects of genetic variants in LIN28B have been 
investigated in three studies in the European and EA populations[14, 17, 18]. However, the 
growth effects of these genetic compositions in non-white populations are less studied. 
African American (AA) women are known to have menarche earlier than white women[19, 
20], and AA children of both sexes tend to have earlier pubertal growth spurts than children 
of European ancestry[21]. In addition, genetic variants in LIN28B have also been found to 
associate with the development of male sexual characteristics (pubic hair and voice change) 
and pubertal growth in boys[14, 17, 18], suggesting shared genetic mechanisms in boys and 
girls. It is therefore logical to question whether menarche-related genetic variations relate to 
growth outcomes similarly in boys and girls as well as in blacks and whites.
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The goal of this study is to explore the genetic influences on pubertal growth. Specifically, 
we investigated the growth effects of menarche-related genetic variation by using 31 single 
nucleotide polymorphisms (SNPs) newly identified in an expanded meta-analysis of GWAS 
of age at menarche among women of European ancestry[22]. Using prospectively collected 
data from a cohort of AA and EA children and adolescents[23], we evaluated the genetic 
effects of 31 menarche-related SNPs on various growth measures, including height, weight, 
and BMI. By assessing the growth effects of these SNPs, we attempted to determine whether 
there were shared genetic influences underlying menarcheal age and pubertal growth 
characteristics. Despite the moderate sample size, the frequently repeated measurements and 
rich phenotypes have provided a unique opportunity to disseminate the growth effects of 
these SNPs.
Methods
Study design and subjects
The study subjects were participants in a longstanding prospective cohort study that was 
established in 1986 to investigate blood pressure development in children and adolescents. 
The study design and data collection process have been described elsewhere[23]. Briefly, 
healthy children between ages 5 and 17 years were recruited from schools in Indianapolis, 
Indiana, and were followed at 6 month intervals prospectively. The cohort included 601 
children, 338 European Americans (EA) and 263 African Americans (AA), who had 
contributed blood samples for genetic analysis. Data on growth-related outcomes were 
assessed during the course of follow-up. The study was approved by a local Institutional 
Review Board. Study subjects or their parents provided informed consent or assent as 
appropriate.
Outcome assessment
Height and weight were measured every six months during follow-up[24]. BMI, defined as 
weight (kilograms)/height (meters)2, was calculated for each follow-up visit. On average, 
each subject contributed 11 repeated measurements. Information on race was ascertained 
based on the subject’s self-report.
SNP selection and genotyping
We selected 31 independent SNPs that have been reported to be associated with age at 
menarche in a recent meta-analysis of GWAS of women of European ancestry[11]. Those 
SNPs were either strongly associated with age at menarche (with reported p-value ≤ 
1×10−8), or associated with both age at menarche and another adult growth outcome (weight 
or height) from this report. Based on their associations with age at menarche and other 
correlated growth traits, we further categorized these SNPs into three groups: Group I 
included 14 SNPs associated with age at menarche only; Group II included 8 SNPs 
associated with both age at menarche and adult BMI, and Group III included 9 SNPs 
associated with both age at menarche and adult height. Detailed descriptions of the SNPs are 
listed in Table 1.
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DNA was extracted for all participants with blood sample available. Genotypes of the 
candidate SNPs were determined using the Sequenom MassArray iPLEX Platform 
(Sequenom, San Diego, CA). The genotyping success rate for each SNP was over 95%. 
Samples with percentage of missing genotypes higher than 2% were removed from the 
study. In the retained samples, all SNPs were in Hardy–Weinberg equilibrium (P value > 
0.05). The allele frequency for each SNP in our data was consistent with that reported for 
populations of European and African descent in the International HapMap Project (http://
hapmap.ncbi.nlm.nih.gov/).
Statistical analysis
Weight and height data spanned between ages 5 and 21 years were used in the analyses. 
Longitudinal analyses were performed using mixed-effect models, which incorporated 
genetic effects on growth outcomes as fixed effects at the population level; and subject-
specific random effects were incorporated into the model to accommodate the potential 
correlations among measures from the same subject. The association between each SNP and 
each measure of growth outcome (weight, height, and BMI) was assessed with adjustment 
for age, race, and sex, assuming a linear age effect on those outcomes. The models included 
the main effects of SNP, age, and the SNP*age interactions. The main effect of SNP 
represented the intercept of the regression line corresponding to the genotype (shift); the age 
effect represented the rate of growth of the reference genotype (slope); and the SNP*age 
interaction tested whether the growth rate differed by genotype. Because the true underlying 
genetic model was unknown, we tested dominant, recessive, and additive genetic models. 
We then tested three-way interactions SNP*age*race in data after adjusting for the effect of 
sex, and SNP*age*sex in data after adjusting for the effect of race. These interaction terms 
allowed us to determine the heterogeneity of the genotype effect on growth rate between 
males and females, and between EA and AA. In order to control for multiple testing, a 
Bonferroni correction was used based on the number of SNPs in each group. A statistical 
significance threshold of 0.0036, 0.0063, and 0.0056 was applied to Group I, II and III, 
respectively. All P values were based on two-sided tests. Genetic associations and 
interactions remained significant after adjustment were reported. We additionally explored 
the genetic effects on various growth outcomes using semiparametric and parametric 
polynomial models to accommodate the potentially nonlinear growth effects. Graphical 
exploration did not show strong enough curvature and the results remain similar to those 
from linear model analysis. We therefore chose to present linear model analysis for 
convenience of inference. All statistical analyses were performed using SAS version 9.2 
software (SAS Institute Inc., Cary, NC, USA).
Results
Characteristics of subjects
Participants consisted of 338 EA (170 boys) and 263 AA (112 boys) whose characteristics at 
the time of enrollment and during the follow-up period are presented in Table 2. At the time 
of study entry, the average age, weight, height, and BMI did not differ significantly between 
males and females for each of EA and AA groups. However, the average age at study entry 
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of EA was younger than that of AA (P=0.0001) and AA were on average heavier, taller, and 
had a higher BMI compared to EA (all P=0.0001).
For the follow-up period, the means of characteristics were obtained by calculating the 
average of the measurements for the follow-up period, incorporating the repeated 
measurements on an individual in the standard errors (Table 2). For either EA or AA groups, 
the mean age and BMI did not differ significantly between males and females. However, 
males were significantly taller than females (P<0.0001) and heavier than females in the EA 
group (P=0.01). EA children on average had more follow-up visits than AA children 
(P=0.0001). During the study period, AA children were of greater weight, height, and BMI 
than EA children (all P < 0.028).
Genetic associations with BMI and weight
In this longitudinal analysis, we observed associations between several SNPs and changes in 
weight and/or BMI during the follow-up period. Associations remained significant after 
adjusting for multiplicity were presented in Table 3. We expected that SNPs associated with 
early menarche were associated with either an increased BMI/weight or a more rapid 
increase in BMI/weight. Of the 14 SNPs with reported association with age at menarche 
only (group I), rs7642134 near VGLL3 was associated with both an increased weight and 
BMI in EA females (P≤0.0016), and the associations were in expected direction as predicted 
by the SNP association with age at menarche. Two other SNPs, rs7821178 near PEX2 and 
rs9635759 near CA10, were associated with more rapid gain in BMI and weight in EA 
(P≤0.0032), respectively; and rs1398217 in SKOR2 was associated with more rapid weight 
gain in AA males (P= 0.0022). However, the three latter associations were not in direction 
predicted by individual SNP associations with age at menarche.
Of the 8 SNPs with reported association with both age at menarche and adult BMI (group 
II), we found 3 SNPs that were significantly associated with changes in weight and/or BMI 
in EA only (Table 3). Two SNPs, rs2815752 near NEGR1 and rs7647305 near ETV5, were 
associated with more rapid gain in both weight and BMI (P≤0.0042); and rs9939609 in FTO 
was associated with an increased BMI only (P=0.0059). The directions of those associations 
were consistent with individual SNP associations with age at menarche.
Of the 9 SNPs with reported associations with both age at menarche and adult height (group 
III), two were found to be significantly associated with weight change in AA only (Table 3). 
Consistent with its association with age at menarche, rs6440003 in ZBTB38 was associated 
with a rapid weight gain (P≤0.0009); whereas rs757608 near TBX2 was also associated with 
a rapid weight gain (P=0.00003), but this association was not in direction predicted by the 
SNP association with age at menarche.
Genetic associations with height
None of the 14 menarche-related SNPs (group I) or the 8 menarche and BMI-associated 
SNPs (group II) were associated with changes in height in our longitudinal analyses. 
However, of the 9 SNPs with reported associations with both age at menarche and adult 
height (group III), three were found to be associated with changes in height in our data 
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(Table 3). We expected that SNPs associated with early menarche were associated with 
either a taller height or a more rapid increase in height during childhood and early 
adolescence. While rs4549631 near LOC728666 was associated with more rapid gain in 
height in AA males (P =0.0011), rs757608 near TBX2 was associated with more rapid gain 
in height in AA males and EA (P≤0.0042). None of these associations were in direction 
predicted by individual SNP associations with age at menarche. Another SNP, rs4800148 in 
CABLES1, was associated with increased height in EA males (P=0.0018), and this 
association was in expected direction based on the SNP association with age at menarche.
Race and sex differences
The associations between candidate SNPs and growth-related outcomes appeared to be race- 
and sex-specific (Table 3). The majority of the associations were observed in the EA group 
and only four SNPs were associated with growth outcomes in the AA population. Out of the 
11 SNPs associated with growth outcomes in our study, the tests for race differences were 
significant for 6 SNPs (P<0.05). On the other hand, approximately 30% of the associations 
were observed in males only, predominantly in AA males, and the tests of sex difference 
were significant for 4 SNPs (P<0.05).
Discussion
In this study, we examined the growth effects of menarche-related genetic variations in EA 
and AA children and adolescents. We found that 11 of the 31 menarche-related SNPs were 
associated with different aspects of pubertal growth, suggesting shared genetic effects 
between age at menarche and pubertal growth and pleiotropic effects of these genetic 
variants. Interestingly, most of the associations were found in relation to the rates of change 
in growth, which are consistent with evidence suggesting that the rate of growth and weight 
gain during early childhood may be more critically related to the timing of puberty in boys 
and girls[26, 27]. In some instances, the identified associations were race- and sex- 
dependent; the fact that we were able to find significant associations after multiplicity 
adjustment in a relatively small sample, in our opinion, gives more credence to the existence 
of these influences. The findings point to the existence of a complex series of genetic 
influences that operate during this time period of rapid growth and development.
The existence of shared mechanisms underlying somatic growth and pubertal development 
is also supported by a recent GWAS meta-analysis among 18,737 subjects of European 
ancestry, in which ten genetic loci were found to be associated with pubertal height and 
growth rates; five of them were also associated with puberty timing[28].The five loci are in 
or near genes PEX2, VGLL3, LIN28B, MAPK3, and ADCY3. The current study assessed 
genetic variants at three of these loci (PEX2, VGLL3 and LIN28B). Our data showed that 
genetic variants at PEX2 and VGLL3 were associated with similar aspects of growth in 
males and females.
Only three studies have examined the associations between genetic variants at LIN28B and 
growth-related outcomes in populations of European ancestry[14, 17, 18]. In this study, we 
included one SNP at LIN28B, rs7759938. The associations between rs7759938 and changes 
in weight, height, and BMI during the follow-up period were not statistically significant, but 
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the direction of the associations was consistent with previous studies. This is likely due to 
our relatively smaller sample size. Additionally, we examined the growth effects of 30 novel 
menarche-related SNPs for the first time.
Out of the 14 SNPs with previously reported associations with menarche only, we found 
only 4 (near or in genes VGLL3, PEX2, CA10, and SKOR2) associated with changes in 
weight and BMI. In addition, for three SNPs the direction of their associations with growth 
outcomes was unexpected, suggesting the possible existence of different regulatory 
mechanisms despite common genetic pathways. The paradoxical effects on puberty and 
somatic growth of these variants suggest the possible involvement of multiple mechanisms 
that need further investigation[29].
Of the 8 SNPs reported to correlate with earlier menarche and greater adult BMI, we found 
three (in or near genes NEGR1, ETV5, and FTO) that were associated with faster increases 
in weight and/or BMI in adolescence. The finding lends support to the notion that common 
genetic pathways underlie the tracking of childhood and adulthood BMI [30, 31]. Of the 9 
SNPs previously associated with menarche and adult height, 4 (in or near genes ZBTB38, 
LOC728666, TBX2 and CABLES) were associated with changes in weight or height; two 
SNPs had effects that were in unexpected directions. Although early puberty is related to 
shorter adult height in both males and females[32, 33], genetic variants for menarche can 
exert distinctive, sex-specific effects on pubertal growth as suggested by Widen et al.[18]. 
Interestingly, we observed these genetic effects on height predominantly in males, consistent 
with previous findings.
Early puberty in males and females is similarly associated with a faster weight gain and 
accelerated growth in infancy and early childhood[34], However, marked sex differences in 
body composition are reported, possibly due to the rise of sex hormones in puberty[35]. 
Females that are younger at menarche have a higher fat mass over fat-free mass that 
coincides with changes in estrogen levels[36], whereas males who experience earlier 
puberty have a higher fat-free mass likely due to changes in androgen levels [37]. It is 
therefore conceivable that early puberty has different effects on adiposity in males and 
females. Although it remains largely unknown whether genetic variants influencing the 
timing of puberty in males and females are the same, one study found a genetic variant at 
LIN28B, rs314276, was associated with early puberty in both sexes[14]. For females age at 
menarche and breast development were typically used to determine puberty whereas voice 
change and pubic hair development were used as indicators for puberty in males[14]. The 
growth effects of rs314276 and its surrogate (rs7759938) have been investigated in three 
studies[14, 17, 18]. The findings of those studies are consistent and supportive of the notion 
that the SNPs are associated with faster height growth during childhood and early 
adolescence in both sexes, but only in females are they associated with an increased weight 
and BMI. However, another partially correlated variant at LIN28B, rs314277, has distinctive 
sex-specific effects on height growth[18]. In our study, we also observed sex-specific 
genetic effects of menarche-related variants on different aspects of growth outcomes. The 
complex interactions between genetic variants and sex may partially explain the apparent 
difference between males and females in early weight gain, insulin sensitivity and hormone 
changes in relation to puberty development and subsequent growth outcomes[38].
Tu et al. Page 7
J Adolesc Health. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
In the current study, we investigated 31 candidate SNPs with previously reported 
associations with age at menarche in EA women[22]. It remains unclear whether genetic 
variants associated with age at menarche in AA women are similar or different. A recent 
GWAS of age at menarche has been performed in AA women[25]. Although no SNPs 
passed the pre-specified threshold for genome-wide significance (P<5×108), this study 
demonstrated that approximately 60% of previously identified menarche loci in EA women 
were associated with menarche in AA women with a relaxed threshold[25], suggesting the 
cross-ethnic generalization of menarche loci. Specifically, 15 out of the 31 candidate SNPs 
in our study were found to be associated with age at menarche in both EA and AA women 
from these reports (Table 1)[22, 25].
What this research does not address is the precise mechanisms by which identified SNPs 
affect the onset of menarche and pubertal growth. The classical work of Grumbach depicts 
puberty as a complex neuroendocrine process, one that marked by the reactivation of the 
hypothalamic-pituitary-gonadal axis, but also influenced by many external factors[39, 40]. 
The neuroendocrine, genetic, and environmental triggers, as well as their interactions, 
involved in the control of age at menarche and onset of pubertal growth remain poorly 
understood. This research highlights the need, and to some extent, the potential target of 
future investigation on the biological functions of these genetic variants.
The study has a number of important strengths. The study was based on prospective growth 
assessments with frequent measurements starting in childhood and repeated well into 
adolescence. The frequently repeated measurements allow us to better quantify the 
characteristics of growth, and to explore genetic associations with longitudinal changes in 
somatic growth, including rates of change of growth outcomes. The inclusion of AA 
subjects in the study cohort has provided valuable data that were unavailable in previous 
studies.
A number of limitations should be acknowledged. First, the study focused on pubertal 
growth outcomes instead of pubertal staging. Age at menarche, as well as changes in 
secondary sexual characteristics such as breast and pubic and facial hair development, and 
voice change were not collected in the original study. Second, the subjects were children of 
school age and no early-in-life growth characteristics were available. It is possible that 
puberty timing-related variants may have important and different growth effects during this 
period, as rapid weight gain in infancy and a faster growth rate within the first 2 years of life 
are critical and have been linked to an earlier puberty[7, 34] and body composition in 
adolescents[38]. Finally, the study power was limited due to the relatively small sample size. 
As a result, genetic associations of moderate effect sizes may not be detected. The analytic 
power was more limited in race and sex-specific subgroup analyses. As in all studies, lack of 
statistical significance could be due to limited power, thus should not be interpreted as 
evidence for lack of association. Further confirmatory studies should be conducted to 
validate the reported findings.
In conclusion, genetic variants associated with menarche timing are found to correlate with 
somatic growth and weight change in adolescents, suggesting shared genetic factors 
underlying age at menarche and pubertal growth. These reported associations appear in 
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some instances to be sex- and race- specific. The findings require replication in other 
populations and large studies. Future studies may identify relationships between these 
genetic variations and the risk for disorders that occur post puberty.
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Implications and Contribution
This study examines the growth effects of menarche-related variants in individuals of 
European and non-European ancestries. The findings indicate that genetic variants 
responsible for age at menarche are associated with pubertal growth in healthy 
adolescents. Data suggest shared genetic influences on menarcheal age and pubertal 
growth.
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